Merz unveils 'Make Your Mark' campaign

Share this article:
A new patient advocacy campaign called “Make Your Mark” was launched April 14 on behalf of Merz Pharmaceuticals, maker of orphan drug Xeomin, a botulinum toxin type A free from accessory proteins. The online effort features the testimonials of national spokespeople—including 2010 Mrs. North Carolina, Dawn Brinkley, and opera singer, writer and actress, Hallie Neil—as well as the personal experiences of people living with cervical dystonia or blepharospasm.
Though the drug has been used abroad since 2005, Xeomin was approved in the US in 2010 for the treatment of adults with cervical dystonia to decrease the severity of abnormal head position and neck pain, and to treat abnormal spasms of the eyelids in adults who have had prior treatment with Botox. Administered as an injectible, Xeomin works to decrease muscle activity, which allows muscles to function more normally for patients diagnosed with either of these conditions.
The web-based campaign was developed by New York agency Medical Dynamics (the public relations AOR), in close partnership with Merz Pharmaceuticals, according to the company's director of marketing, Robert Yanez. This campaign will continue into 2012 and is one of “several initiatives designed to raise awareness of cervical dystonia and blepharospasm and encourage patient dialogue” by Merz Pharmaceuticals, says Yanez.
On the overall objective of the campaign, Yanez explains: “With the help of patient advocates, ‘Make Your Mark' celebrates the inspirational stories of people living with blepharospasm or cervical dystonia, also known as spasmodic torticollis, and aims to raise awareness of these often debilitating conditions.”
Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Features

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.